These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36990424)

  • 1. The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer.
    Zhang ZY; Sun JH; Liang MJ; Wang XP; Guan J; Zhou ZQ
    Int J Biochem Cell Biol; 2023 May; 158():106408. PubMed ID: 36990424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXW10: a male-biased E3 ligase in liver cancer.
    Sahay O; Barik GK; Islam S
    Trends Cancer; 2023 Nov; 9(11):876-878. PubMed ID: 37775405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXW10 promotes hepatocarcinogenesis in male patients and mice.
    Luo YD; Zhang J; Fang L; Zhu YY; You YM; Zhang CC; Zheng P; Zhang LD; Yin LY; Xia F; Bie P; Xie CM
    Carcinogenesis; 2020 Jul; 41(5):689-698. PubMed ID: 31400758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCF-FBXL8 contributes to liver metastasis and stem-cell-like features in colorectal cancer cells by mediating ubiquitination and degradation of TP53.
    Yao J; Wang XP; Yang J; Yang Z; Zhang ZY
    Clin Transl Med; 2023 Mar; 13(3):e1208. PubMed ID: 36855778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXW11 contributes to stem-cell-like features and liver metastasis through regulating HIC1-mediated SIRT1 transcription in colorectal cancer.
    Yao J; Yang J; Yang Z; Wang XP; Yang T; Ji B; Zhang ZY
    Cell Death Dis; 2021 Oct; 12(10):930. PubMed ID: 34642302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
    Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
    Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer.
    Du YL; Liang Y; Shi GQ; Cao Y; Qiu J; Yuan L; Yong Z; Liu L; Li J
    Exp Cell Res; 2020 Oct; 395(1):112176. PubMed ID: 32682784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
    Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
    J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Liu L; Wong CC; Gong B; Yu J
    Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Wu Y; Yang X; Chen Z; Tian L; Jiang G; Chen F; Li J; An P; Lu L; Luo N; Du J; Shan H; Liu H; Wang H
    Mol Cancer; 2019 Apr; 18(1):87. PubMed ID: 30979372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer.
    Ou B; Zhao J; Guan S; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Zheng M; Feng H; Lu A
    Cancer Lett; 2016 Oct; 380(2):457-466. PubMed ID: 27423313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXW10-S6K1 promotes ANXA2 polyubiquitination and KRAS activation to drive hepatocellular carcinoma development in males.
    Liu ZY; Lin XT; Zhang YJ; Gu YP; Yu HQ; Fang L; Li CM; Wu D; Zhang LD; Xie CM
    Cancer Lett; 2023 Jul; 566():216257. PubMed ID: 37277019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2.
    Ma J; Wu Y; Cheng S; Yang W; Zhong L; Li Q; Fang L
    Dig Dis Sci; 2023 May; 68(5):1913-1922. PubMed ID: 36515852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.
    Wang H; Chen Y; Lin P; Li L; Zhou G; Liu G; Logsdon C; Jin J; Abbruzzese JL; Tan TH; Wang H
    J Biol Chem; 2014 Feb; 289(7):4009-17. PubMed ID: 24362026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
    Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
    Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
    Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
    Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
    Peng H; Pan X; Su Q; Zhu LS; Ma GD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRPF19 facilitates colorectal cancer liver metastasis through activation of the Src-YAP1 pathway via K63-linked ubiquitination of MYL9.
    Zhou R; Chen J; Xu Y; Ye Y; Zhong G; Chen T; Qiu L
    Cell Death Dis; 2023 Apr; 14(4):258. PubMed ID: 37031206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression.
    FeiFei W; HongHai X; YongRong Y; PingXiang W; JianHua W; XiaoHui Z; JiaoYing L; JingBo S; Kun Z; XiaoLi R; Lu Q; XiaoLiang L; ZhiQiang C; Na T; WenTing L; YanQing D; Li L
    Cell Death Dis; 2019 Apr; 10(5):351. PubMed ID: 31024008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.